ApprovalTrail

Approval · Notice of Compliance 6360 · 1995

AMIGLYDE-V: Notice of Compliance 6360

Issued November 3, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
6360
Date
November 3, 1995
Company
Ayerst Veterinary LaboratoriesGuelph, Ontario, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Antibiotic

Products in this notice

BrandDINStatus today
AMIGLYDE-V02173336Marketed

Medicinal ingredients